Suppr超能文献

小鼠肝脏及可移植性肝癌中细胞质和线粒体天冬氨酸氨基转移酶同工酶的周转

Turnover of cytoplasmic and mitochondrial aspartate aminotransferase isozymes in mouse liver and transplantable hepatomas.

作者信息

Shaffer J B, Felder M R

出版信息

Arch Biochem Biophys. 1983 Jun;223(2):649-61. doi: 10.1016/0003-9861(83)90629-x.

Abstract

Activities of the cytoplasmic and mitochondrial isozymes of aspartate aminotransferase (aspartate:2-oxoglutarate aminotransferase, EC 2.6.1.1, AAT) in transplantable mouse hepatomas BW7756 and H-4 are reduced when compared to normal adult liver. Both proteins have been purified to homogeneity from a single preparation of mouse liver and monospecific antibodies raised to each isozyme. By quantitative immunotitration analysis, the activity of each isozyme in liver and hepatoma has been shown to correlate with levels of immunoprecipitable protein. Furthermore, for each isozyme, the liver versus hepatoma species is indistinguishable by heat inactivation kinetics, Km's for substrates, and molecular weights. Thus, the reduction of mitochondrial and cytoplasmic AAT activities in hepatoma tissue is due not to alterations in the catalytic activity of the enzyme molecules, but to a decrease in the number of enzyme molecules present. Turnover of the isozymes was studied in liver and hepatoma tissue using in vivo radiolabeling and specific immunoprecipitation techniques. The cytoplasmic isozyme has a similar rate of degradation in liver and hepatoma, while the rate of synthesis of this isozyme in hepatoma is approximately tenfold less than in liver. The mitochondrial isozyme is also degraded at a similar rate in both tissues, but the rate of synthesis is sixfold greater in normal liver tissue than in hepatoma. It is concluded that decreased amounts of both isozymes in hepatoma as compared to liver are the result of a reduction in the rate of synthesis of each isozyme without any change in the rate of degradation.

摘要

与正常成年肝脏相比,可移植性小鼠肝癌BW7756和H - 4中天冬氨酸转氨酶(天冬氨酸:2 - 氧代戊二酸转氨酶,EC 2.6.1.1,AAT)的细胞质和线粒体同工酶活性降低。这两种蛋白质已从单一的小鼠肝脏制剂中纯化至同质,并针对每种同工酶产生了单特异性抗体。通过定量免疫滴定分析,已证明肝脏和肝癌中每种同工酶的活性与免疫沉淀蛋白水平相关。此外,对于每种同工酶,肝脏和肝癌样本在热失活动力学、底物的米氏常数(Km)和分子量方面无法区分。因此,肝癌组织中线粒体和细胞质AAT活性的降低不是由于酶分子催化活性的改变,而是由于存在的酶分子数量减少。使用体内放射性标记和特异性免疫沉淀技术研究了肝脏和肝癌组织中同工酶的周转率。细胞质同工酶在肝脏和肝癌中的降解速率相似,而该同工酶在肝癌中的合成速率比在肝脏中大约低十倍。线粒体同工酶在两种组织中的降解速率也相似,但正常肝脏组织中的合成速率比肝癌中高六倍。得出的结论是,与肝脏相比,肝癌中两种同工酶的量减少是由于每种同工酶合成速率降低,而降解速率没有任何变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验